Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the HeartMate 3™ in a Post-Market Approval Setting: The HeartMate 3 Registry (ELEVATE™)

NCT02497950 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02497950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02497950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the HeartMate 3™ in a Post-Market Approval Setting: The HeartMate 3 Registry (ELEVATE™)
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
October 13, 2015
Completion date
February 28, 2022
Enrollment
540 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, heart failure, ventricular dysfunction